Genome annotation is critical to understand the function of disease variants, especially for clinical applications. To meet this need there are segmentations available from public consortia reflecting varying unsupervised approaches to functional annotation based on epigenetics data, but there remains a need for transparent, reproducible, and easily interpreted genomic maps of the functional biology of chromatin. We introduce here methods for defining chromatin state with a combinatorial epigenomic model using an annotation tool, StatePaintR and a website database, StateHub. Annotations are fully documented with change history and versioning, authorship information, and original source files. The tool calculates quantitative state scores based on genome-wide ranking, allowing prioritization and enrichment testing, facilitating quantitative analysis. StateHub hosts annotation tracks for major public consortia as a resource, and allows users to submit their own alternative models.
Introduction 1 in genomewide assays (e.g. whole genome bisulfite sequencing [Cokus et al., 2008] ). 19 Histone displacement is associated with transcription factor binding and transcriptional 20 activity [Thurman et al., 2012] . In addition, direct binding of transcription factors is 21 measured in ChIP-seq experiments with an antibody directed against a transcription 22 factor or an epitope-tagged version.
23
All these data are compatible with data represented as genomic intervals (in bed 24 format), including CpG islands, annotated transcription start sites, repeat elements, 3 25 UTRs). The input and final (output) processed data format are both as browser extensible 26 data (.bed), a flexible standard for different peak calling methods (e.g. "narrowPeak" 27 and "broadPeak" are types of .bed files).
28
Several machine-learning approaches integrate NGS experiments into annotation 29 tracks [Li et al., 2015] . The goal is to discover epigenomic states and aid in understanding 30 "non-coding" genomic elements (they do not encode protein sequence) in an unbiased 31 but biologically meaningful way. Newly discovered states are likely an amalgam of true 32 functional categories reflected in chromatin biology. The most popular and widely used of 33 these machine learning methods is ChromHMM [Ernst and Kellis, 2012] . Other machine-34 learning approaches include spectral-based learning [Song and Chen, 2015] , inference based 35 on read counts [Mammana and Chung, 2015] , dynamic bayesian networks [Hoffman et al., 36 2012], probabilistic approaches [Hon et al., 2008] , supervised enhancer detection [Santoni, 37 2012] , and other hidden markov methods [Zacher et al., 2014 , Sohn et al., 2015 , Biesinger 38 et al., 2013 . However, a software framework for expert or rule-based segmentations 39 is lacking. Such methodology is needed for integrating different experimental data 40 (including non-NGS data) in a reproducible way, reflecting both the novel insights gained 41 from the machine learning methods and our current understanding of genome biology.
42
Here we introduce StateHub and StatePaintR for generating and documenting models 43 in a transparent and reproducible fashion. StateHub is a public resource for storing 44 annotation models, state definitions and associated data in a shareable, referenceable 45 form. The StatePaintR package implements these models and state definitions to produce 46 annotation tracks. We show that StatePaintR can be used to rapidly annotate large 47 collections of public data for summarizing epigenomics data or annotation of variants. 48 We show how annotations gracefully degrade, in that cell types or tissues with missing 49 data types are annotated appropriately based upon available information. We show 50 some use cases, and describe how StatePaintR uses ChIP-seq data to rank within states, 51 making quantitative analysis possible.
52

Results
53
A framework for rules-based annotation 54 In order to assign chromatin states, it is necessary to account for the complex interplay 55 of input from genomic annotations and cell-type-specific experimental data sources 56 that define and demarcate functional regions of the genome [Rando, 2013] . We could 57 implement such a model from a simple decision tree. From such a tree it is possible to 58 produce a satisfactory annotation, from any set of marks. However, it would be complex 59 to implement, to maintain and to update. Some marks are indicative of regulatory 60 status in one context, but have quite different properties depending on which other 61 marks are available. For example, H3K4me1 is generally consistent with enhancers, 62 but is not sufficient on its own to designate a regulatory element as active, poised, 63 primed or bivalent. Consequently, in order to capture meaning there are different trees 64 to make for different combinations of available data. Computationally they have to 65 be put in the right order to avoid erroneous overwriting of information-rich categories 66 with information-poor ones. Thus, decision trees are not general enough to cover most 67 Figure 1 . Mapping datasets to functional significance annotations. Experimental data and external database annotations are combined into abstraction layers (columns), integrated to produce chromatin states (rows) from the decision matrix. StatePaintR produces state assignments by iteratively comparing the marks that are present in each segment with each row of data in the table. The values of color-coded squares signify relationship between data and state: 0 (light red) the feature/data type negates the state but is not required to be present, 1 (light green) feature is consistent with the state but not required, 2 (red) if the feature is required to be available and negates the state, and 3 (green) it is both required and consistent with the state. Information content (sum of row values) of states increases from top to bottom. For the example, red dotted arrows indicate non-matching rows, and green arrows indicate matching rows. The state call corresponds to the last matched row.
regions. We previously used a custom annotation of Roadmap tissues based on the 117 approach described in this manuscript to identify locus-specific tissue enrichment in 118 Figure 2 . Annotation of public epigenomics data sets. Annotations of 77 cell types from the Roadmap Epigenomics consortium, including some Roadmap-processed ENCODE data, selected for their high quality with default model. Roadmap tissues are clustered and color coded at left according to the same color scheme used in Roadmap publications [Roadmap Epigenomics et al., 2015] . Table 1 . Annotation of public datasets. Data from the indicated public consortia were downloaded and processed in StatePaintR. The resulting annotation files and browser sessions are available from the StateHub web page under each model page.
variants associated with Parkinson's disease [Coetzee et al., 2016] . In that study we 119 displayed locus-by-tissue enrichment as a heat-map. Here we present a similar analysis 120 using our new StateHub model as the basis for an alternative visualization. Since 121 we showed that Parkinson's disease variants are primarily associated with enhancers 122 and promoters [Coetzee et al., 2016] , we plotted the 95% range of credible values for 123 enrichment in enhancers and promoters vs background SNPs (matched for GC content 124 & minor allele frequency). Each locus (row) is plotted against a selection of tissues in 125 Roadmap (figure 3).
126
5/22 Figure 3 . Locus-and tissue-specific enrichment of Parkinson's GWAS variants GWAS data and LD proxies ≥ 0.8. Bars: 95% credible range for enrichment in active states vs SNPs in the region with similar minor allele frequency and LD < 0.8, for each of 4 independent genetic loci. Significant enrichment profiles for roadmap tissues are displayed in color (REMC lineage-specific colors); non-significant are gray.
Evaluation of two models with respect to cancer methylation 
133
From previous work CpG islands containing temporarily silenced (poised) genes by 134 polycomb repressive complex in normal tissues may acquire DNA methylation during 135 cancer formation resulting in permanent silencing [Gal-Yam et al., 2008 , Teschendorff et al., 136 2016 . While the segments called EPR and PPR were associated with hypermethylated 137 probes in ovarian cancer across tissues, the magnitude of enrichment was not great (see 138 figure 4, "Model 1"), and it remained possible that our state definitions were too broad. 139 One hypothesis is that poised promoters are distinguishable by the presence or 140 absence of focussed H3K27me3, in particular the narrowPeak calls (as opposed to broad, 141 low-level enrichment from broadPeak files used in model 1). To address this hypothesis, 142 we repeated the analysis in figure 4 for an alternative model (model 2; "focused poised 143 promoter") in which H3K27me3 is called as both broadPeak and narrowPeaks. We use 144 the H3K27me3 broadPeak file as in the previous model to identify repressed regions, and 145 H3K27me3 narrowPeaks to identify poised states (EPR and PPR). Enhancers lacking 146 H3K27Ac and H3K27me3 were classified as weak enhancers and promoters (EWR and 147 PWR, not shown in figure 4 ). Regulatory elements with these properties have been also 148 been called "primed" [Calo and Wysocka, 2013] .
149
We found greater enrichment when we defined poised states in this way (compare 150 model 2 (focused poised promoter) with model 1 (default) in figure 4). The hypermethy-151 lated ovarian cancer CpGs were more enriched in EPR, PPR, and SCR states as defined 152 in the focused poised promoter model relative to the default model, and hypomethylated 153 probes were enriched only in HET and SCR states (not shown). The odds ratio of 154 enrichment for hypermethylated CpGs in EPR and PPR from the default model fell in 155 the a range from between 0 and 5. However, the enrichment of the hypermethylated 156 probes in our focused poised promoter model was > 5 in PPR and > 10 in EPR (figure 4, 157 focused poised promoter figure 3 using either of two different state models (model 1 and model 2) from StateHub, "Default" and "Focused Poised Promoter", which differ in the treatment of poised promoters. Y-axis range is the same for both plots. Both models distinguish hypermethylated probes in the poised state but model 2 is more selective than model 1. In this model (2) 
Enhancer predictions
177
To use ChIP-seq data for quantitative analysis, we ranked within each state by peak score 178 from Macs2 output (generic peak height). We programmed StatePaintR to rank each state 179 by normalizing on a scale of 1-1000, 1000 being the highest rank. StatePaintR ranks the 180 required dataset(s) for each state (i.e. assigned "3" in the decision matrix). To evaluate 181 the ranking function, we measured area under the precision-recall-gain curve (AUPRG) 182 using the set of experimentally validated human and mouse noncoding fragments with 183
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gene enhancer activity as assessed in transgenic mice (VISTA enhancer browser and 184 [Visel et al., 2006] ). We randomly sampled 100 enhancers from 7 VISTA tissues to 185 evaluate different aspects of our models (training), and then used the remainder of the 186 data to test our enhancer predictions against previously published predictions using the 187 same data sets.
188
Some states, including the ones that are germane for enhancer prediction, reference 189 more than one required (matrix value 3) dataset, and therefore it was necessary to 190 optimize the best method for ranking based on > 1 ChIP-seq experiment. We computed 191 the average, median and ceiling functions of ranks across multiple ChIP-seq tracks. The 192 three methods were comparable, but median and average produced the best results (S2 193 Figure) .
194
There are three required marks for active enhancers in our model, but if one of 195 them is not informative for active enhancer prediction, using the ceiling "max" method 196 would produce false positives when this mark has the highest peak rank. Therefore we 197 interrogated which marks are informative using a leave-one-out approach. We found 198 that leaving out H3K4me1 significantly improved our predictions, whereas leaving out 199 the other marks did not (S3 Figure) .
200
Next we assessed AUPRG of different state calls vs VISTA enhancers and found 201 that predictive power descends in order AR + EAR > EAR > AR > RPS > EPRC > 202 etc (S4 Figure) . When we tried combinations of states the highest precision recall gain 203 was observed for EAR, EARC, AR and ARC added together (S4 Figure) , and this was 204 greater than other combinations and than any of the state calls individually, suggesting 205 that H3K27Ac is the most informative predictor of enhancers.
206
Since H3K4me1 does not improve predictions and is the only thing that distinguishes 207 between AR and EAR (by its presence or absence), an improved model would consolidate 208 AR and EAR into a single state and reassign "1" to H3K4me1 instead of "3", leaving 209 this mark exclusively to define weak (or primed) promoters. [Rajagopal et al., 2013] , DELTA [Lu et al., 2015] , CSIANN [Firpi et al., 215 2010], and REPTILE [He et al., 2017] for held-out data using AUPRG (S5 Figure) [Flach 216 and Kull, 2015 Figure) . Our predictions compared favorably to EnhancerFinder and 220 CSIANN which had an average rank > 6 across the different tissues; heart, midbrain, 221 hindbrain, neural tube and limb. Predictions are only available for these tissues. Thus, 222 StatePaintR ranking is useful for drawing quantitative comparisons between different 223 models, making predictions, or prioritizing regions for functional evidence.
224
Discussion
225
We created a platform for hosting, browsing, and generating new genome annotation 226 models called StateHub. The StateHub framework makes it possible to specify combina-227 tions of genomic data as they relate to regions of functional significance in epigenetically 228 marked chromatin. In addition we created a software package, StatePaintR, that facili-229 tates the use of StateHub models to generate browser tracks for bioinformatic analyses. 230 We showed how StatePaintR can be used as part of a workflow with uniformly processed 231 data to generate reproducible annotations from public and private data.
232
Our framework does not replace current machine learning methods, the aim of 233 which is to discover states. But these methods suffer from certain drawbacks that we 234 have addressed with a rules-based approach that provides greater transparency and 235 reproducibility. For example, it is often the case with machine-learning methods that 236 more states are discovered than immediately understood, and there have been different 237 solutions proposed. During discovery, one could iteratively reduce the number of states, 238 minimizing the number of similar or redundant combinations of histone marks. Then 239 the number of discovered states would depend on the number of unique data types 240 used for learning and their distribution around known features. This brittleness makes 241 replication in different settings (with different labs or types of experiments) impractical. 242 Our method avoids these issues, allowing users to specify a model of the epigenome 243 in a matrix (as in figure 1 ) that accounts for all known possibilities. Thus, we built a 244 comprehensive framework for a rules-based annotation, reflecting current hypotheses (or 245 models) of the epigenome.
246
A significant drawback of our approach is that some unusual combinations of marks 247 that may have biological function will be ignored. This has much to do with the fact that 248 StatePaintR is not for discovering novel states, but rather for annotating the genome 249 according to a specific, existing model. Nonetheless, the label assignment step of other 250 chromatin state discovery tools also suffers the same limitations; states are aggregated or 251 optimized in an iterative fashion based on prior knowledge and assumptions. ENCODE 252 for example has published tracks for both ChromHMM and Segway that include multiple 253 states with similar names (e.g. "Tss" vs. "TssF" from ChromHMM, and "EnhF1" vs. 254 "EnhF3" from Segway [Hoffman et al., 2013] ). To resolve discrepancies between the two 255 methods, the authors of those studies proposed a combined analysis to simplify the 256 number of state labels and summarize discovery using a rule-based metric not unlike 257 a StateHub model. Thus, they classified regions into 7 types "emphasizing biologically 258 meaningful differences" [Hoffman et al., 2013] . In direct comparisons we found that our 259 own annotations exhibited greater similarity to the combined analysis than to either 260 of the Segway or ChromHMM tracks separately (not shown). Whatever the protocol, 261 the basic problem persists; machine-learning is able to provide insight into what the 262 categories are, but not how many categories there should be. Currently this remains the 263 exclusive province of the biologist.
264
One of the additional challenges is compatibility between data sets. In order for two or 265 more cell types to be annotated according to the same model, it is necessary to combine 266 each of the cell types for the training. One solution is concatenation of genomes [Hoffman 267 et al., 2013] . Another approach is to jointly model epigenomes in parallel, as proposed 268 in Integrative and Descriminative Epigenome Annotation System (IDEAS) [Zhang et al., 269 2016] . This approach has the distinctive advantage of also modeling segment boundaries. 270 Our approach does not model boundaries, but does offer some advantages. One is 271 reproducibility: StatePaintR always produces the same annotation independently for 272 10/22 each cell type from the same model. Secondly, even samples with different types of 273 data or missing data result in compatible annotations because they come from the same 274 model. Third, the models, composed of a 2D matrix with a range of 4 values, are 275 relatively easy to understand and author. Every file produced in StatePaintR contains a 276 record of the model ID, genome version and all the source files. Clinicians working with 277 human genetics will value consistency and reproducibility across datasets. We produced 278 annotations for REMC, ENCODE, IHEC and blueprint and made these available on the 279 StateHub website for the two models described in this paper. The website also has links 280 to browser sessions where they can be explored and used to create figures. A fourth 281 advantage is speed: samples can be processed in parallel and there is no computationally 282 expensive learning step.
283
A final feature that is very useful is the ranking by peak score (figure S5 Figure) . Using 284 this scheme, we investigated what states contribute most to true enhancers (S2 Figure-S4 285 Figure) . We found that H3K27Ac defined the best predictive subset of annotations for 286 VISTA enhancers. We also investigated different approaches for handling multiple peak 287 calls for a state and found the median to be optimal (S2 Figure) , and incorporated this 288 method as the default behavior of StatePaintR. When we compared our predictions to 289 held-out data, they were comparable to the best enhancer predictions [He et al., 2017 , 290 Rajagopal et al., 2013 and ENCODE enhancers [Dunham et al., 2012] and on the web 291 (unpublished).
292
We demonstrated a workflow wherein new models generate annotations, which 293 are used to test predictions against experimental data, and then in turn to make 294 improvements to old models. We anticipate that this will be valuable in testing new ideas 295 and hypotheses generated from unsupervised methods. The ability to rank features also 296 aids in prioritizing variants for GWAS and studies of somatic mutations. Knowing which 297 variants overlap features in the epigenomic landscape of a particular cell type is key. In 298 the future, other methods may become available for incorporation into StatePaintR but 299 the models described in StateHub will remain stable.
300
Conclusions
301
We introduced two new computational resources, an online database of chromatin state 302 models and processed genome segmentations called StateHub, and an R/Bioconductor 303 tool called StatePaintR which translates epigenomics files into segmentations using these 304 models. One may annotate incomplete datasets rapidly and sensibly according to a 305 single model specification that gracefully degrades to lesser annotations with missing 306 data. Annotations have header documentation with genome version, StateHub model, 307 and the names of source files and their mappings. These tools document segmentations 308 and state labels precisely as they are used in individual studies and to allow comparisons 309 between evolving models of epigenomic states as they relate to NGS experiments. They 310 also enable mixing of epigenomic states with other types of data, such as 3D looping 311 assays, transcription factors, primary sequence features such as position weight matrices, 312 or disease variants.
313
Materials and Methods
314
StateHub models
315
The main text makes reference to two models in StateHub (www.statehub.org). 316 The unique identifiers of these models are as follows:
"Default" (model 317 ID: 581ff9f246e0fb06b4b6b178) and "Focused Poised promoter" (model ID: 318 11/22 5813b67f46e0fb06b493ceb0). In each of the two models presented and discussed in 319 this paper we chose a naming convention for our states reflecting biological function.
320
Annotation of public datasets
321
Preprocessed peak calls were obtained from the IHEC and ENCODE websites (see 322  Table 1 ) for hg19, and where possible hg38. Where possible we used IDR (Irreproducible 323 discovery rate) processed narrowPeak calls for DHS and broadPeaks for broad marks 324 (H3K27Ac, H3K4me1, H3K27me3, H3K36me3) unless otherwise specified in the model. 325 A complete manifest with filenames, plus all annotation tracks are available on the 326 StateHub website.
327
Analysis of methylation data
328
To select methylation variants, we analyzed the Infinium HM450 data of 114 ovarian tumor 329 samples [Patch et al., 2015] and 216 control normal Fallopian tube samples [Teschendorff 330 et al., 2016] . The differentially methylated probes were called (FDR-corrected p-value 331 < 0.01) and divided into hyper-and hypo-methylated probes (difference β ≥ 0.3 cancer 332 vs. normal).
333
Enrichment calculations 334
Parkinson's GWAS variants. A conjugate beta-binomial distribution was used for 335 estimating the 95% highest density interval (HDI) for the credible differences of the 336 enrichment of single SNPs with Parkinson's at each locus for observed vs. random 337 SNPs, matched for both GC content and minor allele frequency. Matching random 338 SNPs were generated using the webtool SNPsnap [Pers et al., 2015] . Comparison of 339 models with demethylated regions. Enrichment calculations were done as in figure 4, 340 using either of two different state models from StateHub, default and focused poised 341 promoter, which differ in the treatment of poised promoters.Enrichment in genomic 342 annotations. Analyses and graphics were produced using the SegTools package [Buske 343 et al., 2011] . Figure S1 . Relationship between data and runtime StatePaintR takes only a few seconds to run. The exact time depends on the number number of unique segments (lines of data) created by overlapping genomic intervals of all input files, cumulative. Thus, 128 Roadmap tissues can be run in 10s × 128 ≈ 1, 280s (21m).
14/22 S2 Figure   356midbrain neural tube Ranked ChIP-seq peak scores for multiple marks were used to rank active enhancers (H3K4me1 + H3K27Ac + DHS) by 3 methods (median, mean, ceiling) and compared to a sample (n = 100) of experimentally validated enhancers. The average or median of three marks was a better predictor than ceiling. The choice of function is subservient to choice of data for ranking-if one of the three is less informative, it will produce false positives when using the max method-therefore it is better to eliminate uninformative marks. See also S4 Figure. 15/22 S3 Figure   357midbrain neural tube Combinations of marks were used to predict active enhancers by the max ranking method (as in S2 Figure) and compared to enhancer score. "All" includes regulatory (H3K4me1), active (H3K27Ac), and core (DHS). We also tried a leave-one-out strategy for each of these categories in succession. Leaving out H3K4me1 ("no regulatory") produced superior predictions, suggesting that its inclusion made the predictions less specific.
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S4 Figure   358We tested different chromatin states for their ability to predict true enhancers under the poised focused promoter model. Active enhancers exhibited the greatest predictive power under the precision recall gain curve.
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S5 Figure   35918/22
